SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
AMN Healthcare reported fourth-quarter earnings of $26.4 million, a nearly 31 percent year-over-year jump that helped the San Diego-based medical staffing company post record revenue and earnings in 2016.
Local biotech Dermata Therapeutics LLC is bringing in $10 million to fuel the development of its dermatological products, the company announced Feb. 16.
As a new administration continues its transition in Washington, D.C., many are wondering what changes are still to come in the first 100 days. As organizations on the front lines helping people access health care services in the San Diego region, we share the public’s uncertainty about what’s in store for the future.
Dauntless Pharmaceuticals, a San Diego biotech with an innovative business model, scored an additional $25 million to enter the clinic with its first investigational drug.
San Francisco-based life-science investment firm Versant Ventures announced the formation of Jecure Therapeutics, a San Diego-based biotech company with a locally developed liver disease platform.
Liquid biopsy company Biocept Inc. has hired ex-Trovagene executive Michael Terry to join their leadership team as senior vice president of commercial operations.
NucleusHealth, a cloud-based medical image management company based in San Diego, said it is working on a pilot project with the Dana-Farber/Harvard Cancer Center in Boston.
Carlsbad drugmaker Ionis Pharmaceuticals Inc. is receiving a $75 million payment from its partner Bayer to advance two anti-blood-clotting programs.
Local biotech Retrophin Inc. has hired William “Bill” Rote as senior vice president of research and development.
Local medical device maker NuVasive Inc. reported strong financial performance for 2016, indicating good times are ahead for 2017.
Local science technology company Illumina Inc. has added three new startups to its accelerator program, which mentors and invests money into early-stage companies in the genomics technology space.
BIOTECH: Spun Out of TSRI, Co.’s Biotech to Tap Genetic Advances
A recent infusion of cash launched a local biotech out of stealth mode with the biggest VC backing of the year so far in San Diego.
Another local medical device firm is dabbling in software.
Local gene therapy company Angionetics Inc. has been granted a Fast Track designation from the U.S. Food and Drug Administration for its lead drug candidate Generx.